Efficacy and Safety of Tiropramide in the Treatment of Patients With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-blind, Non-inferiority Trial, Compared With Octylonium

BACKGROUND/AIMS: Antispasmodics such as octylonium are widely used to manage irritable bowel syndrome (IBS) symptoms. However, the efficacy and safety of another antispasmodic, tiropramide, remain uncertain. We aimed to evaluate the efficacy and safety of tiropramide compared with octylonium in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kang Nyeong, Lee, Oh Young, Choi, Myung-Gyu, Sohn, Chong Il, Huh, Kyu Chan, Park, Kyung Sik, Kwon, Joong Goo, Kim, Nayoung, Rhee, Poong-Lyul, Myung, Seung-Jae, Lee, Joon Seong, Lee, Kwang Jae, Park, Hyojin, Lee, Yong Chan, Choi, Suck Chei, Jung, Hye-Kyung, Jee, Sam Ryong, Choi, Chang Hwan, Kim, Gwang Ha, Park, Moo In, Sung, In Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Neurogastroenterology and Motility 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895597/
https://www.ncbi.nlm.nih.gov/pubmed/24466452
http://dx.doi.org/10.5056/jnm.2014.20.1.113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895597/
https://www.ncbi.nlm.nih.gov/pubmed/24466452
http://dx.doi.org/10.5056/jnm.2014.20.1.113

Ejemplares similares